Page 7 - Human Use News Today

– Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally – – Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million – – Q1 Retail Prescription Equivalents...

PTC Therapeutics May 2024 Patient Living with PKU Forward-Looking Statements ...

Explore how Mercodia’s cost-effective bioanalytical solutions enable drug development success

SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon.The Phase 1 clinical trial, protocol number...

ARS Pharmaceuticals (SPRY), Tuesday announced the submission of Day 180 response for Neffy's Marketing Authorization Application to the Committee for Medicinal Products for Human Use of the European Medicines Agency, expecting to receive the opinion on the drug in the second quarter of 2024.

As April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023.

On April 25, 2024, the Committee for Medicinal Products for Human Use (“CHMP”) adopted a positive opinion, recommending the granting of marketing authorization for Biogen Netherlands...

Investegate announcements from Truqap recommended for EU breast cancer approval

AstraZeneca announces that Truqap in combination with Faslodex has been recommended by the Committee for Medicinal Products for Human Use of the European Medicines Agency for approval in the...

COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...